397 related articles for article (PubMed ID: 24921412)
1. Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011.
Patrick SW; Kaplan HC; Passarella M; Davis MM; Lorch SA
J Perinatol; 2014 Nov; 34(11):867-72. PubMed ID: 24921412
[TBL] [Abstract][Full Text] [Related]
2. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
3. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.
Maalouf FI; Cooper WO; Slaughter JC; Dudley J; Patrick SW
J Pediatr; 2018 Aug; 199():151-157.e1. PubMed ID: 29754866
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
5. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
[TBL] [Abstract][Full Text] [Related]
6. Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016.
Milliren CE; Gupta M; Graham DA; Melvin P; Jorina M; Ozonoff A
Hosp Pediatr; 2018 Jan; 8(1):15-20. PubMed ID: 29263122
[TBL] [Abstract][Full Text] [Related]
7. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
8. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
[TBL] [Abstract][Full Text] [Related]
9. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of neonatal abstinence syndrome in the United States.
Corr TE; Hollenbeak CS
Addiction; 2017 Sep; 112(9):1590-1599. PubMed ID: 28612362
[TBL] [Abstract][Full Text] [Related]
12. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
[TBL] [Abstract][Full Text] [Related]
13. Wide Variation Found in Care of Opioid-Exposed Newborns.
Bogen DL; Whalen BL; Kair LR; Vining M; King BA
Acad Pediatr; 2017; 17(4):374-380. PubMed ID: 27889436
[TBL] [Abstract][Full Text] [Related]
14. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
15. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
16. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
[TBL] [Abstract][Full Text] [Related]
17. Improving Care for Neonatal Abstinence Syndrome.
Patrick SW; Schumacher RE; Horbar JD; Buus-Frank ME; Edwards EM; Morrow KA; Ferrelli KR; Picarillo AP; Gupta M; Soll RF
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244809
[TBL] [Abstract][Full Text] [Related]
18. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
19. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
20. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]